Search results

• 2024

  Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial

  Jackson, T. L., Desai, R., Wafa, H. A., Wang, Y., Peacock, J., Peto, T., Chakravarthy, U., Dakin, H., Wordsworth, S., Lewis, C., Clinch, P., Ramazzotto, L., Neffendorf, J. E., Lee, C. N., O'Sullivan, J. M. & Reeves, B. C., 6 Jul 2024, In: Lancet. 404, 10447, p. 44-54 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Wet Macular Degeneration 100%
  • Stereotactic Radiotherapy 100%
  • Injection 61%
  • Therapeutic Procedure 46%
  • Vasculotropin 23%
  1 Citation (Scopus)

  28 Downloads (Pure)